Insiders Buy the Holdings of FXZ ETF

Form 4 filings show 10.7% of the First Trust Materials AlphaDEX Fund’s (FXZ) weighted holdings experienced insider buying in the past six months, highlighting targeted insider activity in chemicals names. International Flavors & Fragrances (IFF), a 2.08% position in FXZ worth $4,196,009 (#24 holding), saw three directors/officers buy shares (total purchases of roughly $342k, $994k and $1.00m in May and August 2025), while FMC Corp., a 1.05% position worth $2,111,276 (#30 holding), had two directors buy shares in November 2025 (about $136k and $96k). These filings may signal management confidence in select materials constituents and offer a conviction signal for investors evaluating FXZ’s mid-sized holdings, though the overall ETF exposure to each name remains modest.

Analysis

Form 4 data show 10.7% of the weighted holdings in the First Trust Materials AlphaDEX Fund (FXZ) recorded insider purchases within the past six months, signaling concentrated insider activity within select materials names rather than broad-based buying. International Flavors & Fragrances (IFF) is a 2.08% position in FXZ valued at $4,196,009 and ranked #24 in the fund; three insiders filed purchases: Kevin O'Byrne (Director) 4,500 shares on 05/22/2025 at $76.05 ($342,240), CEO J. Erik Fyrwald 15,300 shares on 08/07/2025 at $64.95 ($993,714), and Paul J. Fribourg (Director) 15,450 shares on 08/07/2025 at $64.80 ($1,001,183), while the stock's last trade was $65.13.

FMC Corp. is a smaller FXZ holding (#30) at roughly $2,111,276 or ~1.05% of the ETF; two directors purchased shares in November 2025 (Carol Anthony Davidson 10,000 shares at $13.60 for $135,957 on 11/05/2025 and John Mitchell Raines 7,000 shares at $13.77 for $96,390 on 11/13/2025) with the last trade at $12.95. These filings include a CEO purchase at IFF and multiple director purchases at both IFF and FMC, which typically registers as a management-confidence signal but does not by itself quantify future operational improvement or earnings trajectory.

The market-impact and sentiment outputs are mildly positive (overall sentiment score 0.28; per-ticker: FXZ 0.3, IFF 0.6, FMC 0.4), but ETF-level exposure to each name is modest so the trades are unlikely to materially move FXZ performance absent broader sector momentum; investors should treat these Form 4s as conviction signals that warrant follow-up rather than immediate large-scale reallocations. Limitations include unknown motives (tax planning, option exercises or routine allocations) and lack of concurrent fundamental updates in the article, so confirmation via upcoming earnings, additional Form 4s or analyst revisions is required before repositioning.

Key Decisions for Investors

• Consider a tactical, limited long exposure to IFF given the CEO and multiple director purchases—size positions modestly and use position limits because IFF is only a 2.08% weight in FXZ,
• Avoid making large changes to FXZ allocations solely on these insider filings since each name represents a small share of the ETF and sector-level confirmation is needed,
• Set alerts for subsequent Form 4s, quarterly results and guidance for IFF and FMC to confirm management conviction and monitor price action relative to insider purchase prices,
• If adding exposure, employ risk management such as stop-losses or hedges given insider purchases can be non-informational and the article provides no direct operational or earnings catalysts